{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:30Z","timestamp":1793723790301,"version":"4.6.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions"},{"name":"Beijing Ditan Hospital, Xuzhou Hospital, Capital Medical University, Special Program for Clinical Research and Scientific Innovation Transformation","award":["KCZL202401, KCDL202402"],"award-info":[{"award-number":["KCZL202401, KCDL202402"]}]},{"name":"Beijing Municipal Health Commission High-Level Public Health Technical Talent Program","award":["Discipline Backbone 02-28"],"award-info":[{"award-number":["Discipline Backbone 02-28"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372245"],"award-info":[{"award-number":["82372245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Qing Lan Project of Jiangsu Province"},{"name":"the Training Programs of Innovation and Entrepreneurship for College Students in Jiangsu Province and Xuzhou Medical University","award":["DYLC202408, 202510313010"],"award-info":[{"award-number":["DYLC202408, 202510313010"]}]},{"name":"a project funded by Jiangsu Commission of Health","award":["Z2025009"],"award-info":[{"award-number":["Z2025009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00806-3","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:44:59Z","timestamp":1777301099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ALDH2 inhibits FASN stabilization via the E3 ligase CBL to suppress lipid accumulation and liver cancer development"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiucheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renxian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"806_CR1","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/ijms24032409","volume":"24","author":"S Berkemeyer","year":"2023","unstructured":"Berkemeyer S. Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. Int J Mol Sci. 2023;24(3):2409. https:\/\/doi.org\/10.3390\/ijms24032409.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"806_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Singal AG, Kanwal F, Lampertico P, Buti M, Sirlin CB, et al. Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology. Nat Rev Gastroenterol Hepatol. 2023;20(12):797\u2013809. https:\/\/doi.org\/10.1038\/s41575-023-00818-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"806_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2023","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(4):203\u201322. https:\/\/doi.org\/10.1038\/s41575-022-00704-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"806_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023;164(5):766\u201382. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033.","journal-title":"Gastroenterology"},{"issue":"2","key":"806_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019;156(2):477\u2013e491. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.065. 1.","journal-title":"Gastroenterology"},{"issue":"4","key":"806_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, et al. Management of Hepatocellular Carcinoma: A Review. JAMA Surg. 2023;158(4):410\u201320. https:\/\/doi.org\/10.1001\/jamasurg.2022.7989.","journal-title":"JAMA Surg"},{"issue":"5","key":"806_CR7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/HEP.0000000000000005","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y, et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology. 2023;78(5):1602\u201324. https:\/\/doi.org\/10.1097\/HEP.0000000000000005.","journal-title":"Hepatology"},{"key":"806_CR8","doi-asserted-by":"publisher","first-page":"116021","DOI":"10.1016\/j.biopha.2023.116021","volume":"170","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liu J, Chen Z, Zheng J, Wang Y, Dong J. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review. Biomed Pharmacother. 2024;170:116021. https:\/\/doi.org\/10.1016\/j.biopha.2023.116021.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"806_CR9","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Fu L. The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment. Acta Pharm Sin B. 2021;11(6):1400\u201311. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.008.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"806_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/jpet.123.001898","volume":"389","author":"D Yang","year":"2024","unstructured":"Yang D, Hu Y, Yang J, Tao L, Su Y, Wu Y, et al. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development. J Pharmacol Exp Ther. 2024;389(2):163\u201373. https:\/\/doi.org\/10.1124\/jpet.123.001898.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"806_CR11","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.7150\/ijbs.93075","volume":"20","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Lin XH, Guo HY, Shi X, Zhang DY, Sun JL, et al. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. Int J Biol Sci. 2024;20(7):2763\u201378. https:\/\/doi.org\/10.7150\/ijbs.93075.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"806_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2019.06.018","volume":"71","author":"W Seo","year":"2019","unstructured":"Seo W, Gao Y, He Y, Sun J, Xu H, Feng D, et al. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles. J Hepatol. 2019;71(5):1000\u201311. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.018.","journal-title":"J Hepatol"},{"issue":"5","key":"806_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/hep.29006","volume":"65","author":"G Hou","year":"2017","unstructured":"Hou G, Chen L, Liu G, Li L, Yang Y, Yan HX, et al. Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice. Hepatology. 2017;65(5):1628\u201344. https:\/\/doi.org\/10.1002\/hep.29006.","journal-title":"Hepatology"},{"key":"806_CR14","doi-asserted-by":"publisher","first-page":"101919","DOI":"10.1016\/j.redox.2021.101919","volume":"41","author":"S Zhong","year":"2021","unstructured":"Zhong S, Li L, Liang N, Zhang L, Xu X, Chen S, et al. Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver. Redox Biol. 2021;41:101919. https:\/\/doi.org\/10.1016\/j.redox.2021.101919.","journal-title":"Redox Biol"},{"issue":"8","key":"806_CR15","doi-asserted-by":"publisher","first-page":"e112304","DOI":"10.15252\/embj.2022112304","volume":"42","author":"P Yao","year":"2023","unstructured":"Yao P, Zhang Z, Liu H, Jiang P, Li W, Du W. p53 protects against alcoholic fatty liver disease via ALDH2 inhibition. EMBO J. 2023;42(8):e112304. https:\/\/doi.org\/10.15252\/embj.2022112304.","journal-title":"EMBO J"},{"issue":"6","key":"806_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","volume":"45","author":"AR Terry","year":"2024","unstructured":"Terry AR, Hay N. Emerging targets in lipid metabolism for cancer therapy. Trends Pharmacol Sci. 2024;45(6):537\u201351. https:\/\/doi.org\/10.1016\/j.tips.2024.04.007.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"806_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/cancers16071313","volume":"16","author":"A Gupta","year":"2024","unstructured":"Gupta A, Das D, Taneja R. Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors. Cancers (Basel). 2024;16(7):1313. https:\/\/doi.org\/10.3390\/cancers16071313.","journal-title":"Cancers (Basel)"},{"key":"806_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/jcar.JCar_15_20","volume":"20","author":"W Khan","year":"2021","unstructured":"Khan W, Augustine D, Rao RS, Patil S, Awan KH, Sowmya SV, et al. Lipid metabolism in cancer: A systematic review. J Carcinog. 2021;20:4. https:\/\/doi.org\/10.4103\/jcar.JCar_15_20.","journal-title":"J Carcinog"},{"issue":"1","key":"806_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41389-023-00460-8","volume":"12","author":"D Vanauberg","year":"2023","unstructured":"Vanauberg D, Schulz C, Lefebvre T. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies. Oncogenesis. 2023;12(1):16. https:\/\/doi.org\/10.1038\/s41389-023-00460-8.","journal-title":"Oncogenesis"},{"issue":"6","key":"806_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/0008-5472.CAN-23-0966","volume":"84","author":"J Huang","year":"2024","unstructured":"Huang J, Tsang WY, Fang XN, Zhang Y, Luo J, Gong LQ, et al. FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma. Cancer Res. 2024;84(6):855\u201371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0966.","journal-title":"Cancer Res"},{"issue":"4","key":"806_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/hep.32359","volume":"76","author":"H Wang","year":"2022","unstructured":"Wang H, Zhou Y, Xu H, Wang X, Zhang Y, Shang R, et al. Therapeutic efficacy of FASN inhibition in preclinical models of HCC. Hepatology. 2022;76(4):951\u201366. https:\/\/doi.org\/10.1002\/hep.32359.","journal-title":"Hepatology"},{"key":"806_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2021.07.029","volume":"519","author":"H Li","year":"2021","unstructured":"Li H, Chen Z, Zhang Y, Yuan P, Liu J, Ding L, et al. MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis. Cancer Lett. 2021;519:161\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2021.07.029.","journal-title":"Cancer Lett"},{"issue":"1","key":"806_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40164-021-00218-1","volume":"10","author":"SZ Zhang","year":"2021","unstructured":"Zhang SZ, Zhu XD, Feng LH, Li XL, Liu XF, Sun HC, et al. PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma. Exp Hematol Oncol. 2021;10(1):25. https:\/\/doi.org\/10.1186\/s40164-021-00218-1.","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"806_CR24","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41388-020-1156-0","volume":"39","author":"L Gu","year":"2020","unstructured":"Gu L, Zhu Y, Lin X, Tan X, Lu B, Li Y. Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. 2020;39(11):2437\u201349. https:\/\/doi.org\/10.1038\/s41388-020-1156-0.","journal-title":"Oncogene"},{"key":"806_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.mce.2017.10.010","volume":"470","author":"X Liao","year":"2018","unstructured":"Liao X, Song L, Zhang L, Wang H, Tong Q, Xu J, et al. LAMP3 regulates hepatic lipid metabolism through activating PI3K\/Akt pathway. Mol Cell Endocrinol. 2018;470:160\u20137. https:\/\/doi.org\/10.1016\/j.mce.2017.10.010.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"806_CR26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41416-022-02115-8","volume":"128","author":"H You","year":"2023","unstructured":"You H, Zhang N, Yu T, Ma L, Li Q, Wang X, et al. Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis. Br J Cancer. 2023;128(6):992\u20131004. https:\/\/doi.org\/10.1038\/s41416-022-02115-8.","journal-title":"Br J Cancer"},{"key":"806_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijbiomac.2022.11.312","volume":"226","author":"H You","year":"2023","unstructured":"You H, Yuan D, Li Q, Zhang N, Kong D, Yu T, et al. Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis. Int J Biol Macromol. 2023;226:996\u20131009. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.312.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"806_CR28","doi-asserted-by":"publisher","first-page":"mjae014","DOI":"10.1093\/jmcb\/mjae014","volume":"16","author":"HJ You","year":"2024","unstructured":"You HJ, Li Q, Ma LH, Wang X, Zhang HY, Wang YX, et al. Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis. J Mol Cell Biol. 2024;16(4):mjae014. https:\/\/doi.org\/10.1093\/jmcb\/mjae014.","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"806_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s13402-023-00889-4","volume":"47","author":"HJ You","year":"2024","unstructured":"You HJ, Ma LH, Wang X, Wang YX, Zhang HY, Bao ES, et al. Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis. Cell Oncol (Dordr). 2024;47(2):639\u201355. https:\/\/doi.org\/10.1007\/s13402-023-00889-4.","journal-title":"Cell Oncol (Dordr)"},{"issue":"11","key":"806_CR30","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1038\/s41401-025-01586-8","volume":"46","author":"HJ You","year":"2025","unstructured":"You HJ, Zhang HY, Zhong YJ, Liu RY, Yang L, Jiang R, et al. Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcription. Acta Pharmacol Sin. 2025;46(11):3036\u201352. https:\/\/doi.org\/10.1038\/s41401-025-01586-8.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"806_CR31","doi-asserted-by":"publisher","first-page":"e0680","DOI":"10.1097\/HC9","volume":"9","author":"F Kong","year":"2025","unstructured":"Kong F, Bao E, Zhong Y, Wang Y, Liu R, Zhang H, et al. HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression. Hepatol Commun. 2025;9(5):e0680. https:\/\/doi.org\/10.1097\/HC9.","journal-title":"Hepatol Commun"},{"issue":"6","key":"806_CR32","doi-asserted-by":"publisher","first-page":"e12703","DOI":"10.1111\/cpr.12703","volume":"52","author":"F Kong","year":"2019","unstructured":"Kong F, Zhou K, Zhu T, Lian Q, Tao Y, Li N, et al. Interleukin-34 mediated by hepatitis B virus X protein via CCAAT\/enhancer-binding protein alpha contributes to the proliferation and migration of hepatoma cells. Cell Prolif. 2019;52(6):e12703. https:\/\/doi.org\/10.1111\/cpr.12703.","journal-title":"Cell Prolif"},{"key":"806_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-3578-9_6","volume":"1418","author":"Z Wang","year":"2016","unstructured":"Wang Z, Jensen MA, Zenklusen JC. A Practical Guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol. 2016;1418:111\u201341. https:\/\/doi.org\/10.1007\/978-1-4939-3578-9_6.","journal-title":"Methods Mol Biol"},{"key":"806_CR34","doi-asserted-by":"publisher","unstructured":"Zhang J, Baran J, Cros A, Guberman JM, Haider S, Hsu J, et al. International cancer genome consortium data portal\u2014a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026. https:\/\/doi.org\/10.1093\/database\/bar026.","DOI":"10.1093\/database\/bar026"},{"key":"806_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol. 2016;1418:93\u2013110. https:\/\/doi.org\/10.1007\/978-1-4939-3578-9_5.","journal-title":"Methods Mol Biol"},{"key":"806_CR36","doi-asserted-by":"publisher","first-page":"913743","DOI":"10.3389\/fgene.2022.913743","volume":"13","author":"W Hu","year":"2022","unstructured":"Hu W, Liu D, Li R, Qian H, Qiu W, Ye Q, et al. Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma. Front Genet. 2022;13:913743. https:\/\/doi.org\/10.3389\/fgene.2022.913743.","journal-title":"Front Genet"},{"issue":"43","key":"806_CR37","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"806_CR38","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkab1128","volume":"50D1","author":"A Kamburov","year":"2022","unstructured":"Kamburov A, Herwig R. ConsensusPathDB 2022: molecular interactions update as a resource for network biology. Nucleic Acids Res. 2022;50D1:D587\u201395. https:\/\/doi.org\/10.1093\/nar\/gkab1128.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"806_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41467-017-00299-9","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017;8(1):347. https:\/\/doi.org\/10.1038\/s41467-017-00299-9.","journal-title":"Nat Commun"},{"issue":"12","key":"806_CR40","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41374-020-0465-9","volume":"100","author":"F Kong","year":"2020","unstructured":"Kong F, Li N, Tu T, Tao Y, Bi Y, Yuan D, et al. Hepatitis B virus core protein promotes the expression of neuraminidase 1 to facilitate hepatocarcinogenesis. Lab Invest. 2020;100(12):1602\u201317. https:\/\/doi.org\/10.1038\/s41374-020-0465-9.","journal-title":"Lab Invest"},{"key":"806_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12985-015-0416-z","volume":"12","author":"F Kong","year":"2015","unstructured":"Kong F, You H, Zhao J, Liu W, Hu L, Luo W, et al. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-alpha related apoptosis inducing ligand) TRAIL in hepatoma cells. Virol J. 2015;12:192. https:\/\/doi.org\/10.1186\/s12985-015-0416-z.","journal-title":"Virol J"},{"issue":"2","key":"806_CR42","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4143\/crt.2020.397","volume":"53","author":"F Kong","year":"2021","unstructured":"Kong F, Tao Y, Yuan D, Zhang N, Li Q, Yu T, et al. Hepatitis B Virus Core Protein Mediates the Upregulation of C5alpha Receptor 1 via NF-kappaB Pathway to Facilitate the Growth and Migration of Hepatoma Cells. Cancer Res Treat. 2021;53(2):506\u201327. https:\/\/doi.org\/10.4143\/crt.2020.397.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"806_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12964-021-00714-1","volume":"19","author":"H You","year":"2021","unstructured":"You H, Yuan D, Bi Y, Zhang N, Li Q, Tu T, et al. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis. Cell Commun Signal. 2021;19(1):33. https:\/\/doi.org\/10.1186\/s12964-021-00714-1.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"806_CR44","doi-asserted-by":"publisher","first-page":"21081","DOI":"10.1038\/s41598-025-07905-7","volume":"15","author":"G Wang","year":"2025","unstructured":"Wang G, Ye X, Lu T, Yang Y, Sun B, Xiao H. Integrated plasma metabolomics and lipidomics profiling highlight distinctive signatures with hashimoto\u2019s thyroiditis. Sci Rep. 2025;15(1):21081. https:\/\/doi.org\/10.1038\/s41598-025-07905-7.","journal-title":"Sci Rep"},{"issue":"1","key":"806_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","volume":"23","author":"Y Mo","year":"2024","unstructured":"Mo Y, Han Y, Chen Y, Fu C, Li Q, Liu Z, et al. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol Cancer. 2024;23(1):274. https:\/\/doi.org\/10.1186\/s12943-024-02195-5.","journal-title":"Mol Cancer"},{"issue":"1","key":"806_CR46","doi-asserted-by":"publisher","first-page":"100721","DOI":"10.1016\/j.jlr.2024.100721","volume":"66","author":"Z Deng","year":"2025","unstructured":"Deng Z, Liu L, Xie G, Zheng Z, Li J, Tan W, et al. Hsp90alpha promotes lipogenesis by stabilizing FASN and promoting FASN transcription via LXRalpha in hepatocellular carcinoma. J Lipid Res. 2025;66(1):100721. https:\/\/doi.org\/10.1016\/j.jlr.2024.100721.","journal-title":"J Lipid Res"},{"issue":"1","key":"806_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41419-025-07500-8","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang C, Huang G, Zhang Z, Wang Q, Liu X, et al. Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1\/FASN\/ACC pathway and anti-inflammatory effect of IL10. Cell Death Dis. 2025;16(1):245. https:\/\/doi.org\/10.1038\/s41419-025-07500-8.","journal-title":"Cell Death Dis"},{"issue":"8","key":"806_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/revneuro-2017-0013","volume":"28","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chen X, Zhao Y, Ponnusamy M, Liu Y. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer\u2019s disease. Rev Neurosci. 2017;28(8):861\u20138. https:\/\/doi.org\/10.1515\/revneuro-2017-0013.","journal-title":"Rev Neurosci"},{"issue":"7","key":"806_CR49","doi-asserted-by":"publisher","first-page":"167958","DOI":"10.1016\/j.bbadis.2025.167958","volume":"1871","author":"Y Li","year":"2025","unstructured":"Li Y, Shan J, Liu S, Shen Y, Niu L, Mao Q, et al. TRIM34 inhibits triple-negative breast cancer progression by attenuating fatty acid synthesis via facilitating FASN ubiquitination. Biochim Biophys Acta Mol Basis Dis. 2025;1871(7):167958. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167958.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"806_CR50","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41419-024-07168-6","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Nie J, Jiang H, Li A, Zhong N, Tong W, et al. VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. Cell Death Dis. 2024;15(11):788. https:\/\/doi.org\/10.1038\/s41419-024-07168-6.","journal-title":"Cell Death Dis"},{"issue":"2","key":"806_CR51","doi-asserted-by":"publisher","first-page":"bbab574","DOI":"10.1093\/bib\/bbab574","volume":"23","author":"W Zhang","year":"2022","unstructured":"Wang C, Tan X, Tang D, Gou Y, Han C, Ning W, et al. GPS-Uber: a hybrid-learning framework for prediction of general and E3-specific lysine ubiquitination sites. Brief Bioinform. 2022;23(2):bbab574. https:\/\/doi.org\/10.1093\/bib\/bbab574.","journal-title":"Brief Bioinform"},{"issue":"10","key":"806_CR52","doi-asserted-by":"publisher","first-page":"2003404","DOI":"10.1002\/advs.202003404","volume":"8","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xia Y, Wang F, Luo M, Yang K, Liang S, et al. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression. Adv Sci (Weinh). 2021;8(10):2003404. https:\/\/doi.org\/10.1002\/advs.202003404.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"806_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00018-023-04820-w","volume":"80","author":"K Zhang","year":"2023","unstructured":"Zhang K, Yang C, Zhou X, Liang J, Guo J, Li M, et al. TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN. Cell Mol Life Sci. 2023;80(6):168. https:\/\/doi.org\/10.1007\/s00018-023-04820-w.","journal-title":"Cell Mol Life Sci"},{"issue":"32","key":"806_CR54","doi-asserted-by":"publisher","first-page":"23505","DOI":"10.1074\/jbc.M113.473801","volume":"288","author":"V Chitalia","year":"2013","unstructured":"Chitalia V, Shivanna S, Martorell J, Meyer R, Edelman E, Rahimi N. c-Cbl, a ubiquitin E3 ligase that targets active beta-catenin: a novel layer of Wnt signaling regulation. J Biol Chem. 2013;288(32):23505\u201317. https:\/\/doi.org\/10.1074\/jbc.M113.473801.","journal-title":"J Biol Chem"},{"key":"806_CR55","doi-asserted-by":"publisher","first-page":"1223977","DOI":"10.3389\/fnagi.2023.1223977","volume":"15","author":"T Seike","year":"2023","unstructured":"Seike T, Chen CH, Mochly-Rosen D. Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1223977.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"806_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","volume":"26","author":"IP Gudivada","year":"2025","unstructured":"Gudivada IP, Amajala KC. Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. Curr Genomics. 2025;26(1):48\u201380. https:\/\/doi.org\/10.2174\/0113892029308243240709073945.","journal-title":"Curr Genomics"},{"issue":"5","key":"806_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1566523222666220825110147","volume":"24","author":"C Liu","year":"2024","unstructured":"Liu C, Shi J, Lin B, Zhou M, Shan D, Nie J, et al. SHR6390 Combined with Cabozantinib Inhibits Tumor Progression in the Hepatocellular Carcinoma Mouse Model. Curr Gene Ther. 2024;24(5):453\u201364. https:\/\/doi.org\/10.2174\/1566523222666220825110147.","journal-title":"Curr Gene Ther"},{"issue":"3","key":"806_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/0115665232274223231017052707","volume":"24","author":"J Wang","year":"2024","unstructured":"Wang J, Sun L, Liu Y, Zhang Y. FIGNL1 Promotes Hepatocellular Carcinoma Formation via Remodeling ECM-receptor Interaction Pathway Mediated by HMMR. Curr Gene Ther. 2024;24(3):249\u201363. https:\/\/doi.org\/10.2174\/0115665232274223231017052707.","journal-title":"Curr Gene Ther"},{"issue":"9","key":"806_CR59","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"Ye W, Wang J, Zheng J, Jiang M, Zhou Y, Wu Z. Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis. Protein Pept Lett. 2024;31(9):706\u201313. https:\/\/doi.org\/10.2174\/0109298665330781240830042601.","journal-title":"Protein Pept Lett"},{"issue":"3","key":"806_CR60","doi-asserted-by":"publisher","first-page":"e12772","DOI":"10.1111\/cpr.12772","volume":"53","author":"B Hu","year":"2020","unstructured":"Hu B, Lin JZ, Yang XB, Sang XT. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell Prolif. 2020;53(3):e12772. https:\/\/doi.org\/10.1111\/cpr.12772.","journal-title":"Cell Prolif"},{"issue":"4","key":"806_CR61","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4251\/wjgo.v15.i4.617","volume":"15","author":"XC Feng","year":"2023","unstructured":"Feng XC, Liu FC, Chen WY, Du J, Liu H. Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy. World J Gastrointest Oncol. 2023;15(4):617\u201331. https:\/\/doi.org\/10.4251\/wjgo.v15.i4.617.","journal-title":"World J Gastrointest Oncol"},{"key":"806_CR62","doi-asserted-by":"publisher","first-page":"115146","DOI":"10.1016\/j.jep.2022.115146","volume":"292","author":"YN Cao","year":"2022","unstructured":"Cao YN, Yue SS, Wang AY, Xu L, Hu YT, Qiao X, et al. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity. J Ethnopharmacol. 2022;292:115146. https:\/\/doi.org\/10.1016\/j.jep.2022.115146.","journal-title":"J Ethnopharmacol"},{"key":"806_CR63","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2023.07.002","volume":"206","author":"P Xia","year":"2023","unstructured":"Xia P, Liu DH, Wang D, Wen GM, Zhao ZY. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway. Free Radic Biol Med. 2023;206:125\u201333. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.07.002.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"806_CR64","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41416-024-02574-1","volume":"130","author":"Y Chen","year":"2024","unstructured":"Chen Y, Feng Y, Lin Y, Zhou X, Wang L, Zhou Y, et al. GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14\/FASN axis and GPX4. Br J Cancer. 2024;130(5):755\u201368. https:\/\/doi.org\/10.1038\/s41416-024-02574-1.","journal-title":"Br J Cancer"},{"issue":"1","key":"806_CR65","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41420-022-01241-9","volume":"8","author":"Z Han","year":"2022","unstructured":"Han Z, Liu M, Xie Y, Zeng K, Zhan Z, Chen Y, et al. Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis. Cell Death Discov. 2022;8(1):445. https:\/\/doi.org\/10.1038\/s41420-022-01241-9.","journal-title":"Cell Death Discov"},{"issue":"10","key":"806_CR66","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale B, Cheng M, Park KS, Kaniskan HU, Xiong Y, Jin J. Advancing targeted protein degradation for cancer therapy. Nat Rev Cancer. 2021;21(10):638\u201354. https:\/\/doi.org\/10.1038\/s41568-021-00365-x.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"806_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrc.2017.105","volume":"18","author":"D Senft","year":"2018","unstructured":"Senft D, Qi J, Ronai ZA. Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat Rev Cancer. 2018;18(2):69\u201388. https:\/\/doi.org\/10.1038\/nrc.2017.105.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"806_CR68","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/cells8050498","volume":"8","author":"CL Lyle","year":"2019","unstructured":"Lyle CL, Belghasem M, Chitalia VC. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. Cells. 2019;8(5):498. https:\/\/doi.org\/10.3390\/cells8050498.","journal-title":"Cells"},{"issue":"1","key":"806_CR69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-024-03062-3","volume":"43","author":"Y Su","year":"2024","unstructured":"Su Y, Meng L, Ge C, Liu Y, Zhang C, Yang Y, et al. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling. J Exp Clin Cancer Res. 2024;43(1):142. https:\/\/doi.org\/10.1186\/s13046-024-03062-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"806_CR70","doi-asserted-by":"publisher","first-page":"996","DOI":"10.7150\/thno.51646","volume":"11","author":"J Song","year":"2021","unstructured":"Song J, Liu Y, Liu F, Zhang L, Li G, Yuan C, et al. The 14-3-3sigma protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1\/2 signaling pathway. Theranostics. 2021;11(3):996\u20131015. https:\/\/doi.org\/10.7150\/thno.51646.","journal-title":"Theranostics"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00806-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00806-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00806-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:22:48Z","timestamp":1781140968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00806-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00806-3","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the principles of the Declaration of Helsinki. The approval regarding the collection of tissue samples was obtained from the Ethics Committees of Outdo Biotech Co., Ltd (Approval Number: SHYJS-CP-1810007, SHYJS-CP-1304054). The mouse experiments were approved by the Animal Care and Use Committee of Xuzhou Medical University (Approval Number: 202307T012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}